SV2001000212A - A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT - Google Patents

A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT

Info

Publication number
SV2001000212A
SV2001000212A SV2000000212A SV2000000212A SV2001000212A SV 2001000212 A SV2001000212 A SV 2001000212A SV 2000000212 A SV2000000212 A SV 2000000212A SV 2000000212 A SV2000000212 A SV 2000000212A SV 2001000212 A SV2001000212 A SV 2001000212A
Authority
SV
El Salvador
Prior art keywords
acetildinaline
carboplatin
paclitaxel
combination
game
Prior art date
Application number
SV2000000212A
Other languages
Spanish (es)
Inventor
Ronald Lynn Merriman
Wayne Daniel Klohs
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2001000212A publication Critical patent/SV2001000212A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA ACETILDINALINA EN COMBINACIÓN CON PACLITAXEL Y/O CARBOPLATINA ES SINERGISTICA PARA TRATAR EL CANCER.ACETILDINALINE IN COMBINATION WITH PACLITAXEL AND / OR CARBOPLATIN IS SYNERGISTIC TO TREAT CANCER.

SV2000000212A 1999-11-10 2000-11-07 A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT SV2001000212A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16488999P 1999-11-10 1999-11-10
US22256100P 2000-08-03 2000-08-03

Publications (1)

Publication Number Publication Date
SV2001000212A true SV2001000212A (en) 2001-10-25

Family

ID=26860956

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000212A SV2001000212A (en) 1999-11-10 2000-11-07 A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT

Country Status (17)

Country Link
EP (1) EP1229916A2 (en)
JP (1) JP2003513912A (en)
KR (1) KR20020060226A (en)
CN (1) CN1387438A (en)
AR (1) AR026400A1 (en)
AU (1) AU1583201A (en)
CA (1) CA2386876A1 (en)
GT (1) GT200000194A (en)
HU (1) HUP0203153A3 (en)
IL (1) IL149363A0 (en)
NZ (1) NZ518668A (en)
PA (1) PA8506201A1 (en)
PE (1) PE20011028A1 (en)
PL (1) PL355170A1 (en)
SV (1) SV2001000212A (en)
UY (1) UY26431A1 (en)
WO (1) WO2001034131A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022216A3 (en) * 2001-07-02 2003-05-14 Warner-Lambert Company Compound chemotherapy
PE20050206A1 (en) * 2003-05-26 2005-03-26 Schering Ag PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF HISTONE DEACETILASE
CA2552279C (en) * 2003-12-02 2014-07-15 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
US7951780B2 (en) 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
EP2322217A3 (en) * 2004-07-16 2011-09-28 Pfizer Products Inc. Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
PL2415382T3 (en) 2010-08-06 2013-02-28 Electrolux Home Products Corp Nv Table top dishwasher
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023194441A1 (en) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases

Also Published As

Publication number Publication date
WO2001034131A2 (en) 2001-05-17
AU1583201A (en) 2001-06-06
GT200000194A (en) 2002-05-03
HUP0203153A2 (en) 2003-01-28
CN1387438A (en) 2002-12-25
IL149363A0 (en) 2002-11-10
PL355170A1 (en) 2004-04-05
PE20011028A1 (en) 2001-10-12
UY26431A1 (en) 2000-12-29
EP1229916A2 (en) 2002-08-14
AR026400A1 (en) 2003-02-12
NZ518668A (en) 2004-04-30
PA8506201A1 (en) 2002-12-11
KR20020060226A (en) 2002-07-16
WO2001034131A3 (en) 2002-05-10
JP2003513912A (en) 2003-04-15
HUP0203153A3 (en) 2005-01-28
CA2386876A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
FR2869231B1 (en) THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
AR028296A1 (en) SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
NO20054988D0 (en) Preparations and methods for the treatment of cancer
CR11486A (en) TREATMENT OF UTERINE CANCER AND OVARIO CANCER WITH A PARP INHIBITOR ONLY OR IN COMBINATION WITH ANTI-TUMOR AGENTS
SV2001000212A (en) A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT
MXPA05012421A (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents.
BRPI0212298B8 (en) pharmaceutical composition comprising gabapentin or an analogue thereof and (alpha)-aminoamide and its analgesic use
AR023616A1 (en) COMBINED PREPARATIONS UNDERSTANDING ANTHRACICLINE DERIVATIVES
ES2172171T3 (en) MEDICINAL PRODUCT, CONTAINING YOHIMBINE AND ARGININE, FOR THE TREATMENT OF ERECTILE DYSFUNCTIONS.
DE602004014787D1 (en) ANTI-TUMORAL FORMULATIONS WITH DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMOROUS AGENTS
ES2184341T3 (en) A METHOD FOR THE PREVENTION AND TREATMENT OF Myocardium Dysfunction.
UY26171A1 (en) PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA
ES2159357T3 (en) TERPENOID DERIVATIVES (SARCODICTINES) USEFUL AS ANTITUMOR AGENTS.
AR029451A1 (en) A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY
ATE294585T1 (en) PREVENTION OF COLORECTAL CANCER
AR029958A1 (en) USE OF STRAMUSTIN PHOSPHATE IN THE TREATMENT OF OSEA METASTASIS AND IN THE TREATMENT OF OSEA METASTASIS IN PATIENTS WITH PROSTATE CANCER
RS50681B (en) A combination of a taxane and cyclin-dependent kinase inhibitor
PT1273296E (en) COMBINATION OF ACETILDINALINE AND DOCETAXEL
ECSP003755A (en) COMBINATION CHEMOTHERAPY
DOP2000000092A (en) COMBINATION CHEMOTHERAPY
AR027677A1 (en) A THERAPEUTIC PHARMACEUTICAL COMPOSITION THAT INCLUDES CAMPTOTECHINE AND CYCLOFOSPHAMIDE FOR THE TREATMENT OF CANCER
DE60143681D1 (en) Combination therapy against tumors with substituted acryloyl-distamycin derivatives, taxanes and / or antimetabolites
AR033992A1 (en) SYNERGIC ASSOCIATIONS OF DALFOPRISTINA / QUINUPRISTINA WITH CEFPIROMA THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE KIT OF PRESENTATION OF SUCH ASSOCIATION
PT1351680E (en) UTILIZATION OF ANETOLE-DITIOLETION IN THE PREVENTION AND TREATMENT OF TENOTOXICITY INDUCED BY A DRUG
CO5280204A1 (en) USE OF GLUTAMINE FOR THE PREVENTION OF LATE DIARRHEA INDUCED BY IRINOTECAN

Legal Events

Date Code Title Description
FC Refusal
FC Refusal